Prescriber is the leading UK journal for healthcare professionals focussing on prescribing and medicines management. The journal features articles on all areas of therapeutics and prescribing policy and is fully peer reviewed. The content is relevant and of interest to all prescribers and prescribing policy makers including GPs, pharmacists, nurses and hospital specialists. Access to all content is free to healthcare professionals following registration.Sign up for e-alerts and print copies

Latest News

NHS England restricts primary care prescribing of seven more items

NHS England and NHS Clinical Commissioners have updated their guidance for CCGs on items that should not routinely be prescribed in primary care, adding...Read more

Routine HPV vaccination programme extended to boys

NHS England and Public Health England have announced the expansion of the human papillomavirus (HPV) vaccination programme to a universal programme from 1...Read more

Melatonin licensed for the treatment of jet-lag

The MHRA has approved the licensing of melatonin for the short-term treatment of jet-lag in adults. Two melatonin products have gained marketing...Read more

New safety advice on use of DOACs in patients with antiphospholipid syndrome

In a recent Drug Safety Update, the Medicines and Healthcare products Regulatory Agency (MHRA) has issued new advice on the use of direct-acting oral...Read more

New educational materials simplify oral retinoid pregnancy prevention advice

Following the recommendations of an assessment report from the EMA’s Pharmacovigilance Risk Assessment Committee (PRAC), new Pregnancy Prevention Programme...Read more

Featured Articles

Targeting dyslipidaemia to prevent cardiovascular disease
Dyslipidaemia is a key risk factor for cardiovascular disease, and its identification and treatment is important for both primary and secondary prevention. This article discusses how to screen for dyslipidaemia and optimise lipid-lowering therapy to improve cardiovascular outcomes.
Click here to view

Hypertension clinic drug choices: tips for pharmacist prescribers
In the second of our two-part series on helping pharmacist independent prescribers set up and run a hypertension clinic in primary care, Briegeen Girvin discusses the factors to consider when prescribing and monitoring antihypertensive drugs and statins.
Click here to view

Levothyroxine – not all tablets are the same
Most patients with hypothyroidism tolerate levothyroxine therapy well, but a significant minority are dissatisfied with treatment. Here, the authors examine whether this could be a result of intolerance to the excipients in the specific levothyroxine product prescribed or dispensed.
Click here to view

Web design and marketing agency Leamington Spa